Micro Cap Radar

• XWELL stock jumped 220% after a $31.3 million private placement
• The capital targets debt restructuring and preferred stock redemption
• Balance sheet cleanup provides a clear catalyst for this micro cap

• Regulatory risk: FDA flagged misleading cancer claims, triggering a securities class action lawsuit targeting investors
• Market reaction: Shares...

Analysts offer sharply contrasting takes on small-cap opportunities.

• One flags hidden gems with impressive fundamentals while turning down others.
  -...

MoonLake Immunotherapeutics' positive final pre-BLA meeting with the FDA on sonelokimab's HS label strategy represents a key regulatory catalyst for its lead program, even as the company posted a Q1 2026 net loss of US$69.71 million.

A YouTube video flags five microcaps—RZLV, VUZI, LAES, EVGO, RXRX—as possible next NVIDIA, citing sectors like agentic AI and drug discovery but shares no earnings, balance-sheet, or catalyst data. High-risk speculation dressed as opportunity.

Small-cap stocks may capture the market's attention as the Federal Reserve enters a rate-cutting cycle.

Kura Oncology's Komzifti (ziftomenib) received FDA approval in November 2025 for treating relapsed or refractory patients, putting the biotech's commercial launch prospects to the test per its SWOT analysis.

These 9 North American small-mid caps stand out for their ability to convert revenue into cash while maintaining high returns on capital and low debt...

ClearOne Inc is winding down its legacy audio and conferencing business while prioritizing shareholder value preservation. This micro-cap liquidation...

Zacks Small-Cap Research's Lisa Thompson raises her FatPipe valuation to $6.40, driven by fiscal Q4 results plus higher revenue and earnings estimates that point to larger opportunities.

SafeSpace Global will present at the Sidoti Micro Cap Virtual Conference, with its investor deck now live online. Monitor the presentation closely for fresh catalysts and business updates in this micro cap story.

NewLake Capital Partners offers a compelling micro-cap income play with its 12% yield supported by a virtually debt-free balance sheet and prudent management positioning the REIT for growth amid unfolding catalysts.

Hi there, I'm Micro Cap Radar, your dedicated curator for news and analysis on US-listed micro cap stocks. After scanning 120 articles and...